Pramipexole-treated Parkinson's disease during pregnancy

Movement Disorders : Official Journal of the Movement Disorder Society
Marco MucchiutPaolo Bergonzi

Abstract

There are few reports about drug-related effects on PD pregnancy. We describe the case of a woman affected by PD treated with pramipexole monotherapy during pregnancy. The child, born by caesarean delivery, is healthy, whereas motor disability of the mother progressively increased to the point that levodopa therapy was necessary.

References

Jun 1, 1989·Clinical Neuropharmacology·H AllainG Defawe
Jan 1, 1985·Clinical Neuropharmacology·D G Cook, H L Klawans
Mar 19, 1982·JAMA : the Journal of the American Medical Association·I TurkaljP Krupp
May 1, 1982·Neurology·W C KollerN Biary
Nov 1, 1996·Reproductive Toxicology·D BeltrameG Mazué
Feb 6, 1998·Movement Disorders : Official Journal of the Movement Disorder Society·P HagellE Vinge
Jan 26, 1999·Movement Disorders : Official Journal of the Movement Disorder Society·J Benito-LeónJ Porta-Etessam
May 5, 1999·Neurology·R Saunders-PullmanS Bressman
Jan 14, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·L M ShulmanW J Weiner
Mar 29, 2002·Movement Disorders : Official Journal of the Movement Disorder Society·Michele De MariPaolo Lamberti
Oct 29, 2002·Reproductive Toxicology·Elena RicciMaurizio Bonati

❮ Previous
Next ❯

Citations

Mar 26, 2013·Postgraduate Medical Journal·Kavitha Nagandla, Somsubhra De
Sep 7, 2007·Parkinsonism & Related Disorders·Susan M Calne, Ajit Kumar
Jun 22, 2018·Journal of Neurology·Zeynep TüfekçioğluMurat Emre
Jun 19, 2010·CNS Neuroscience & Therapeutics·Maria Gabriela SánchezThérèse Di Paolo
Jul 8, 2005·Movement Disorders : Official Journal of the Movement Disorder Society·Michael Scott, Muhammad Chowdhury
Dec 18, 2008·Expert Review of Neurotherapeutics·Bradley J RobottomLisa M Shulman
May 4, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Sarah M KranickLawrence I Golbe
Oct 5, 2010·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Sandeep GroverRitushree Kukreti
Sep 2, 2020·Expert Opinion on Drug Safety·Fabrizio StocchiMargherita Torti
Mar 30, 2018·Journal of Inherited Metabolic Disease·O KuseyriT Opladen
May 7, 2020·Movement Disorders Clinical Practice·Caitlin YoungKathryn J Peall
Oct 23, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M DostalC Schaefer
Mar 7, 2020·Frontiers in Neurology·Sara OlivolaLorenza Driul
Aug 14, 2020·ACS Chemical Neuroscience·Sean M WilsonR Nathan Daniels

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Movement Disorders : Official Journal of the Movement Disorder Society
Michele De MariPaolo Lamberti
Movement Disorders : Official Journal of the Movement Disorder Society
Michael Scott, Muhammad Chowdhury
Movement Disorders : Official Journal of the Movement Disorder Society
P HagellE Vinge
Movement Disorders : Official Journal of the Movement Disorder Society
L M ShulmanW J Weiner
© 2021 Meta ULC. All rights reserved